Compound Summary
Compound Name: | Rocephin |
Compound CID: | 9570985 |
Synonyms: | Rocephin Lendacin Longaceph ceftriaxone CEFTRIAXONE SODIUM More... |
Iupac Name: | disodium;(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
InChI: | InChI=1S/C18H18N8O7S3.2Na/c1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7;;/h5,9,15H,3-4H2,1-2H3,(H2,19,20)(H,21,27)(H,23,29)(H,31,32);;/q;2*+1/p-2/b24-8-;;/t9-,15-;;/m1../s1 |
InChIKey: | FDRNWTJTHBSPMW-BBJOQENWSA-L |
Canonical Smiles: | CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-].[Na+].[Na+] |
Isomeric Smiles: | CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)[O-].[Na+].[Na+] |
Molecular Weight: | 598.6 |
Molecular Formula: | C18H16N8Na2O7S3 |
Molecular Weight: | 598.6 |
Molecular Formula: | C18H16N8Na2O7S3 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 14 |
Rotatable Bond Count: | 7 |
Heavy Atom Count: | 38 |
Complexity: | 1120 |
Rocephin | Rocephin |
---|---|
Rocephin |
Lendacin |
Longaceph |
ceftriaxone |
CEFTRIAXONE SODIUM |
Rocephalin |
UNII-R598PB148Q |
Ceftriaxone Sodium USP |
R598PB148Q |
Rocefin |
Rocephine |
74578-69-1 |
Ceftriaxone and Dextrose in Duplex Container |
Tartriakson |
Ceftriaxone disodium |
CEFTRIAXONE SODIUM TRIHYDRATE |
Ro-139904 |
104376-79-6 |
Ceftriaxone Disodium Salt |
Ceftriaxone disodium salt hemi(heptahydrate) |
Rocefalin |
MFCD01750405 |
Ceftriaxone in plastic container |
EINECS 277-930-0 |
Ro 13-9904/001 |
ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER |
SCHEMBL5880185 |
X 13-9904 |
Ceftriaxone disodium salt hydrate |
DTXSID501019136 |
7-(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetylamino-8-oxo-3-(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thiomethyl-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylic acid disodium salt |
MFCD09749665 |
Ceftriaxone sodium hydrate (2:4:7) |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio)methyl)-, disodium salt, (6R-(6alpha,7beta(Z)))- |
Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drosophila melanogaster | 200 | umol/L | 44.01 | 44.1 | 0.1956 | NS | MALES | 33008901 | Inactive | ||||
Drosophila melanogaster | 20 | umol/L | 48.86 | 47.17 | -3.45 | NS | FEMALES | 33008901 | Inactive | ||||
Caenorhabditis elegans | 33 | umol/L | 28 | NS | N2 | 24134630 | Inactive |
Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | 28 | 1 | 1 | |
Drosophila melanogaster | 0.1956 | 1 | 2 |